MREO Financials
Mereo Biopharma Group Plc - Financial statements & key metrics
Stock Price
$0.57
Market Cap
$89.93M
EPS
$-0.25
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$0.00
Gross Profit
$-1.09M
Operating Income
$-47.36M
Net Income
$-43.25M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$76.39M
Total Liabilities
$15.42M
Shareholders Equity
$60.97M
Cash & Equivalents
$69.80M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-32.83M
CapEx
$699000
Free Cash Flow
$-33.53M
Profitability Metrics
Gross Margin
73.4%
Operating Margin
-90.7%
ROE
-0.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is MREO revenue?
MREO's most recent quarterly revenue was $0.00. Annual revenue can be calculated by summing the four most recent quarters.
Is MREO profitable?
MREO reported a loss of $43.25M in the most recent quarter.
What is MREO market cap?
MREO has a market capitalization of $89.93M, making it a small-cap stock.
Does MREO have debt?
View MREO's balance sheet for debt information.
What is MREO cash flow?
MREO's most recent quarterly free cash flow was $-33.53M.